Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults.
Clinical trial NCT01011413 · COMPLETED
Trial details
- NCT number
- NCT01011413
- Sponsor
- Kirby Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2013-06-01
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.